Logo of brjcancerBJC HomepageBJC Advance online publicationBJC Current IssueSubmitting an article to BJCWeb feeds
Br J Cancer. May 1986; 53(5): 661–671.
PMCID: PMC2001387

Second primary neoplasms in patients with retinoblastoma.

Abstract

In a series of 882 retinoblastoma patients, 384 known to have the genetic form of the disease and 498 others, 30 patients developed second primary neoplasms. The spectrum of these second neoplasms is discussed in relation to the forms of treatment used for the retinoblastoma. Cumulative incidence rates of second tumours in the whole series are 2.0% at 12 years after diagnosis and 4.2% after 18 years. For patients with the genetic form of retinoblastoma the cumulative incidence rate after 18 years is 8.4% for all second neoplasms and 6.0% for osteosarcomas alone. The inherent risk among survivors from genetic retinoblastoma of developing an osteosarcoma, excluding all possible effects of treatment, is estimated to be 2.2% after 18 years. Within the field of radiation treatment the cumulative incidence rate for all second neoplasms after 18 years is 6.6% and for osteosarcomas alone 3.7%. There is some evidence that patients with genetic retinoblastoma are particularly sensitive to the carcinogenic effects of radiation. The results also suggest that the use of cyclophosphamide may increase the risk of second primary neoplasms in patients with genetic retinoblastoma. The incidence rates of second primary neoplasms in retinoblastoma survivors reported here are lower than those quoted for previously published series. Evidence from this and other papers strongly suggests an association between retinoblastoma and malignant melanoma.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (1.5M), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Abramson DH, Ellsworth RM, Zimmerman LE. Nonocular cancer in retinoblastoma survivors. Trans Sect Ophthalmol Am Acad Ophthalmol Otolaryngol. 1976 May-Jun;81(3 Pt 1):454–457. [PubMed]
  • Abramson DH, Ronner HJ, Ellsworth RM. Second tumors in nonirradiated bilateral retinoblastoma. Am J Ophthalmol. 1979 May;87(5):624–627. [PubMed]
  • Abramson DH, Ellsworth RM, Kitchin FD, Tung G. Second nonocular tumors in retinoblastoma survivors. Are they radiation-induced? Ophthalmology. 1984 Nov;91(11):1351–1355. [PubMed]
  • Aherne G. Retinoblastoma associated with other primary malignant tumours. Trans Ophthalmol Soc U K. 1974;94(4):938–944. [PubMed]
  • Bader JL, Meadows AT, Zimmerman LE, Rorke LB, Voute PA, Champion LA, Miller RW. Bilateral retinoblastoma with ectopic intracranial retinoblastoma: trilateral retinoblastoma. Cancer Genet Cytogenet. 1982 Mar;5(3):203–213. [PubMed]
  • Bonaïti-Pellié C, Briard-Guillemot ML. Excess of cancer deaths in grandparents of patients with retinoblastoma. J Med Genet. 1980 Apr;17(2):95–101. [PMC free article] [PubMed]
  • Fedrick J, Baldwin JA. Incidence of cancer in relatives of children with retinoblastoma. Br Med J. 1978 Jan 14;1(6105):83–84. [PMC free article] [PubMed]
  • François J. Retinoblastoma and osteogenic sarcoma. Ophthalmologica. 1977;175(4):185–191. [PubMed]
  • François J. Conservative treatment of retinoblastoma. Mod Probl Ophthalmol. 1977;18:113–117. [PubMed]
  • François J, de Sutter E, Coppieters R, de Bie S. Late extraocular tumours in retinoblastoma survivors. Ophthalmologica. 1980;181(2):93–99. [PubMed]
  • Hoefnagel D, McIntyre OR, Storrs RC, Sullivan PB, Maurer LH. Retinoblastoma followed by acute lymphoblastic leukemia. Lancet. 1973 Mar 31;1(7805):725–725. [PubMed]
  • Jensen RD, Miller RW. Retinoblastoma: epidemiologic characteristics. N Engl J Med. 1971 Aug 5;285(6):307–311. [PubMed]
  • Kingston JE, Plowman PN, Hungerford JL. Ectopic intracranial retinoblastoma in childhood. Br J Ophthalmol. 1985 Oct;69(10):742–748. [PMC free article] [PubMed]
  • Kitchin FD, Ellsworth RM. Pleiotropic effects of the gene for retinoblastoma. J Med Genet. 1974 Sep;11(3):244–246. [PMC free article] [PubMed]
  • Knudson AG., Jr Retinoblastoma: a prototypic hereditary neoplasm. Semin Oncol. 1978 Mar;5(1):57–60. [PubMed]
  • LELE KP, PENROSE LS, STALLARD HB. CHROMOSOME DELETION IN A CASE OF RETINOBLASTOMA. Ann Hum Genet. 1963 Nov;27:171–174. [PubMed]
  • Magnasco A, Zingirian M, Cottafava F. Su un raro caso di leucemia istioide a rapida evoluzione, insorta dopo trattamento roeentgenterapico ed antiblastico per retinoblastoma. Ann Ottalmol Clin Ocul. 1967 Mar;93(3):300–308. [PubMed]
  • Meadows AT, Strong LC, Li FP, D'Angio GJ, Schweisguth O, Freeman AI, Jenkin RD, Morris-Jones P, Nesbit ME. Bone sarcoma as a second malignant neoplasm in children: influence of radiation and genetic predisposition for the Late Effects Study Group. Cancer. 1980 Dec 15;46(12):2603–2606. [PubMed]
  • Meadows AT, Baum E, Fossati-Bellani F, Green D, Jenkin RD, Marsden B, Nesbit M, Newton W, Oberlin O, Sallan SG, et al. Second malignant neoplasms in children: an update from the Late Effects Study Group. J Clin Oncol. 1985 Apr;3(4):532–538. [PubMed]
  • Murphree AL, Benedict WF. Retinoblastoma: clues to human oncogenesis. Science. 1984 Mar 9;223(4640):1028–1033. [PubMed]
  • Nuutinen J, Kärjä J, Sainio P. Epithelial second malignant tumours in retinoblastoma survivors. A review and report of a case. Acta Ophthalmol (Copenh) 1982 Feb;60(1):133–140. [PubMed]
  • Peto R, Pike MC, Armitage P, Breslow NE, Cox DR, Howard SV, Mantel N, McPherson K, Peto J, Smith PG. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. I. Introduction and design. Br J Cancer. 1976 Dec;34(6):585–612. [PMC free article] [PubMed]
  • Sagerman RH, Cassady JR, Tretter P, Ellsworth RM. Radiation induced neoplasia following external beam therapy for children with retinoblastoma. Am J Roentgenol Radium Ther Nucl Med. 1969 Mar;105(3):529–535. [PubMed]
  • Schmähl D, Habs M, Lorenz M, Wagner I. Occurrence of second tumors in man after anticancer drug treatment. Cancer Treat Rev. 1982 Sep;9(3):167–194. [PubMed]
  • Strong LC, Herson J, Osborne BM, Sutow WW. Risk of radiation-related subsequent malignant tumors in survivors of Ewing's sarcoma. J Natl Cancer Inst. 1979 Jun;62(6):1401–1406. [PubMed]
  • Strong LC, Herson J, Haas C, Elder K, Chakraborty R, Weiss KM, Majumder P. Cancer mortality in relatives of retinoblastoma patients. J Natl Cancer Inst. 1984 Aug;73(2):303–311. [PubMed]
  • Tefft M, Vawter GF, Mitus A. Second primary neoplasms in children. Am J Roentgenol Radium Ther Nucl Med. 1968 Aug;103(4):800–822. [PubMed]
  • Vogel F. Genetics of retinoblastoma. Hum Genet. 1979 Nov 1;52(1):1–54. [PubMed]
  • Weichselbaum RR, Nove J, Little JB. Skin fibroblasts from a D-deletion type retinoblastoma patient are abnormally X-ray sensitive. Nature. 1977 Apr 21;266(5604):726–727. [PubMed]
  • White L, Ortega JA, Ying KL. Acute non-lymphocytic leukemia following multimodality therapy for retinoblastoma. Cancer. 1985 Feb 1;55(3):496–498. [PubMed]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

Formats:

Related citations in PubMed

See reviews...See all...

Cited by other articles in PMC

See all...

Links

  • Cited in Books
    Cited in Books
    PubMed Central articles cited in books
  • Compound
    Compound
    PubChem Compound links
  • MedGen
    MedGen
    Related information in MedGen
  • PubMed
    PubMed
    PubMed citations for these articles
  • Substance
    Substance
    PubChem Substance links

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...